Literature DB >> 10424852

Are heroin overdose deaths related to patient release after prehospital treatment with naloxone?

G M Vilke1, J Buchanan, J V Dunford, T C Chan.   

Abstract

OBJECTIVE: Naloxone is frequently used by prehospital care providers to treat suspected heroin and opioid overdoses. The authors' EMS system has operated a policy of allowing these patients, once successfully treated, to sign out against medical advice (AMA) in the field. This study was performed to evaluate the safety of this practice.
METHODS: The authors retrospectively reviewed all 1996 San Diego County Medical Examiner's (ME's) cases in which opioid overdoses contributed to the cause of death. The records of all patients who were found dead in public or private residences or died in emergency departments of reasons other than natural causes or progression of disease, are forwarded to the ME office. ME cases associated with opiate use as a cause of death were cross-compared with all patients who received naloxone by field paramedics and then refused transport. The charts were reviewed by dates, times, age, sex, location, and, when available, ethnicity.
RESULTS: There were 117 ME cases of opiate overdose deaths and 317 prehospital patients who received naloxone and refused further treatment. When compared by age, time, date, sex, location, and ethnicity, there was no case in which a patient was treated by paramedics with naloxone within 12 hours of being found dead of an opiate overdose.
CONCLUSIONS: Giving naloxone to heroin overdoses in the field and then allowing the patients to sign out AMA resulted in no death in the one-year period studied. This study did not evaluate for return visits by paramedics nor whether patients were later taken to hospitals by private vehicles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424852     DOI: 10.1080/10903129908958933

Source DB:  PubMed          Journal:  Prehosp Emerg Care        ISSN: 1090-3127            Impact factor:   3.077


  20 in total

Review 1.  Naloxone in opioid poisoning: walking the tightrope.

Authors:  S F J Clarke; P I Dargan; A L Jones
Journal:  Emerg Med J       Date:  2005-09       Impact factor: 2.740

Review 2.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

3.  Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities.

Authors:  Mark Faul; Michael W Dailey; David E Sugerman; Scott M Sasser; Benjamin Levy; Len J Paulozzi
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

Review 4.  Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.

Authors:  Daniel P Wermeling
Journal:  Ther Adv Drug Saf       Date:  2015-02

5.  Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.

Authors:  Leo Beletsky; Robin Ruthazer; Grace E Macalino; Josiah D Rich; Litjen Tan; Scott Burris
Journal:  J Urban Health       Date:  2007-01       Impact factor: 3.671

6.  How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.

Authors:  Joanne Neale; Caral Brown; Aimee N C Campbell; Jermaine D Jones; Verena E Metz; John Strang; Sandra D Comer
Journal:  Addiction       Date:  2018-12-28       Impact factor: 6.526

7.  Injection drug users trained by overdose prevention programs: responses to witnessed overdoses.

Authors:  Stephen E Lankenau; Karla D Wagner; Karol Silva; Aleksandar Kecojevic; Ellen Iverson; Miles McNeely; Alex H Kral
Journal:  J Community Health       Date:  2013-02

8.  EMS runs for suspected opioid overdose: implications for surveillance and prevention.

Authors:  Amy Knowlton; Brian W Weir; Frank Hazzard; Yngvild Olsen; Junette McWilliams; Julie Fields; Wade Gaasch
Journal:  Prehosp Emerg Care       Date:  2013 Jul-Sep       Impact factor: 3.077

9.  Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality.

Authors:  Daniel Kim; Kevin S Irwin; Kaveh Khoshnood
Journal:  Am J Public Health       Date:  2009-01-15       Impact factor: 9.308

10.  Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City.

Authors:  Phillip O Coffin; Crystal Fuller; Liza Vadnai; Shannon Blaney; Sandro Galea; David Vlahov
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.